SARS-CoV-2 on the ocular surface: is it truly a novel transmission route?
Where this comes from
- Record sourced from PubMed, PMID 32788324.
- Also identified by DOI 10.1136/bjophthalmol-2020-316263 and PMC identifier 8380887.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Since December 2019, the novel COVID-19 outbreak has spread rapidly around the globe and infected millions of people. Although the major transmission route of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is considered to be airborne droplets and close contact, the ocular transmission route has been reported with great concern. The current work summarises the characteristics of SARS-CoV-2, the ocular distribution of the major SARS-CoV-2 binding protein, and the experimental and clinical evidence of the ocular transmission route. Although it seems that the likelihood of the ocular surface being an infection gateway is low, SARS-CoV-2 infection or transmission via the ocular surface may cause conjunctivitis and other ocular discomfort. Therefore, good eye protection is an essential safeguard procedure, especially for medical staff.
Medical subject headings
- COVID-19
- Disease Transmission, Infectious
- Eye Infections, Viral
- SARS-CoV-2